SCHEMBL6974

SCHEMBL6974

OP(Cl)Oc1ccccc1OP(O)Cl

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA12 O43570 1/20 0.35
CA4 P22748 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
TSHR P16473 2/20 0.33
TP53 P04637 1/20 0.33
LMNA P02545 2/20 0.32
GAA P10253 2/20 0.32
KMT2A Q03164 1/20 0.32
ALDH1A1 P00352 2/20 0.32
HTT P42858 2/20 0.32
MAPK1 P28482 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
JAK2 O60674 1/20 0.31
MAPT P10636 1/20 0.31
ENPP2 Q13822 1/20 0.31
LTA4H P09960 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL339290 0.87 CA1 (0.31) CA1CA2CA12CA4CA7
SCHEMBL10937183 0.85 CA2 (0.48) CA1CA2CA12CA4CA14
SCHEMBL7600529 0.85 LMNA (0.41) TSHRTP53LMNAKMT2AALDH1A1
SCHEMBL27594718 0.84 SMN1; SMN2 (0.41) TSHRLMNAKMT2AALDH1A1HTT
SCHEMBL7603952 0.79 ALDH1A1 (0.39) CA1CA2CA12CA4CA7
SCHEMBL2571438 0.77 CA2 (0.38) CA1CA2CA12CA4CA7
SCHEMBL3946937 0.76 LTA4H (0.48) CA1CA2CA4TSHRALDH1A1
SCHEMBL10963854 0.74 GPR84 (0.46) TSHRKMT2AALDH1A1MAPK1L3MBTL1
Biphenyl SCHEMBL4749209 0.73 HPGD (0.47) CA1CA2TSHRTP53LMNA
SCHEMBL7771923 0.73 MAPT (0.53) TSHRLMNAKMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743574-B1 Migration imaging members XEROX CORP (US) 2000-12-27 EP claimed
EP-0743573-B1 Method for obtaining image contrast migration imaging members XEROX CORP (US) 2000-09-06 EP claimed
EP-0743573-A2 Method for obtaining image contrast migration imaging members XEROX CORPORATION (US) 1996-11-20 EP claimed
EP-0743574-A2 Migration imaging members XEROX CORPORATION (US) 1996-11-20 EP claimed
US-5563014-A SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT XEROX CORPORATION (US) 1996-10-08 US claimed
US-5514505-A SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE XEROX CORPORATION (US) 1996-05-07 US claimed
US-4537714-A Process for the preparation of lower alkyl esters of N-L-α-aspartyl-L-phenylalanine and of new intermediates for their preparation EPROVA AG FORSCHUNGSINSTITUT (CH) 1985-08-27 US claimed
US-20250368598-A1 CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES BHATTACHARYA SHRABANTI (US) 2025-12-04 US disclosed
US-12107264-B2 Anode active material comprising metal phosphide coating on surface of carbon material, preparation method therefor, nonaqueous lithium secondary battery comprising anode active material, and manufacturing method therefor KOREA ELECTROTECHNOLOGY RESEARCH INSTITUTE (KR) 2024-10-01 US disclosed
US-20240199803-A1 Polycarbonate Resin Composition ASAHI KASEI KABUSHIKI KAISHA (JP) 2024-06-20 US disclosed
EP-4317318-A1 POLYCARBONATE RESIN COMPOSITION Asahi Kasei Kabushiki Kaisha (JP) 2024-02-07 EP disclosed
EP-3587470-B1 SEMICRYSTALLINE POLYPHENYLSULFONE AND ASSOCIATED METHOD OF MAKING AND METHOD OF ADDITIVE MANUFACTURING SHPP GLOBAL TECH BV (NL) 2023-12-06 EP disclosed
US-20230331910-A1 METHOD FOR THE MANUFACTURE OF A MODIFIED POLYCARBONATE SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2023-10-19 US disclosed
US-4423038-A Phosphoryl compounds, pharmaceutical preparations containing such compounds, and their use CIBA-GEIGY CORPORATION (US) 1983-12-27 US disclosed
EP-0074611-A2 Method for production of cephalosporin compounds Takeda Chemical Industries, Ltd. (JP) 1983-03-23 EP disclosed
US-4210660-A CENTRAL NERVOUS SYSTEM DEPRESSANTS, ESPECIALLY ANTIPSYCOTICS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1980-07-01 US disclosed
US-4197243-A ANTIPSYCHOTICS, STRONG CNS DEPRESSANTS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1980-04-08 US disclosed
US-4097487-A CNS DEPRESSANTS, ANTIPSYCHOTICS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JA) 1978-06-27 US disclosed
US-4012399-A ULTRAVIOLET LIGHT ABSORBERS AND STABILIZERS CINCINNATI MILACRON CHEMICALS, INC. (US) 1977-03-15 US disclosed
US-3959220-A Polymer additives comprising transition metal complexes with trivalent phosphorous compounds CINCINNATI MILACRON CHEMICALS, INC. (US) 1976-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250368598-A1 CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES CA4, CA12, CA14 CA1 9/4885CA2 8/4885CA12 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.